|Videos|December 12, 2020
Evaluating long-term safety of micro-bypass implant with phaco in PXG
Author(s)David Hutton, Alex Delaney-Gesing
Tanner Ferguson, MD, Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.
Advertisement
Tanner Ferguson, MD, an ophthalmology resident at the Cleveland Clinic's Cole Eye Institute, discusses findings from the study "Trabecular Micro-bypass Stent Implantation (iStent)" + Phacoemulsification in PXG: Six-Year Outcomes," during the virtual AAO 2020 meeting.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retina Society 2026: MCO-010 optogenetic therapy maintains visual acuity gains through 4 years in advanced RP
2
Retina Society 2026: Medium-dose OCU410 gene therapy cuts geographic atrophy progression by up to 32% in phase 2 trial
3
Retina Society 2026: LUGANO secondary data show reduced treatment burden with vorolanib insert despite missed primary end point
4
Beyond the phenotype: Aqueous humor sampling moves retinoblastoma toward personalized therapy
5